Cited by 63HIV Research and TreatmentHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Retroviral Rebound Syndrome after Cessation of Suppressive Antiretroviral Therapy in Three Patients with Chronic HIV Infection

Colven, Roy, Harrington, Robert D., Spach, David H., Cohen, Calvin J., Hooton, Thomas M.·2000·Annals of Internal Medicine

Abstract

BACKGROUND: Although viral rebound follows cessation of suppressive antiretroviral therapy in chronic HIV infection, a viremic clinical syndrome has not been described. OBJECTIVE: To describe a retroviral syndrome associated with cessation of effective antiretroviral therapy in chronic HIV infection. DESIGN: Case reports. SETTING: Outpatient HIV specialty clinics in Seattle, Washington, and Boston, Massachusetts. PATIENTS: Three patients with chronic HIV infection who discontinued suppressive antiretroviral therapy. MEASUREMENTS: Clinical course, plasma HIV RNA levels, and CD4 cell counts before, during, and after cessation of antiretroviral therapy. RESULTS: Within 6 weeks after stopping antiretroviral therapy, each patient experienced a clinical illness that resembled a primary HIV syndrome. This coincided with a marked increase in HIV RNA level and, in two of three patients, a decrease in CD4 cell count. After antiretroviral therapy was restarted, each patient's symptoms rapidly resolved in association with resuppression of HIV RNA and increase in CD4 cell count or percentage. CONCLUSION: A retroviral rebound syndrome similar to that seen in primary HIV syndrome can occur in patients with chronic HIV infection after cessation of suppressive antiretroviral therapy.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-133-6-200009190-00010

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 1 references

Research works printed but not linked: 9

  1. 10.1001/jama.1997.03550010072043 · DOI
  2. 10.1056/NEJM199807023390107 · DOI
  3. Jubault V, 1998, AIDS, 12, 2358
  4. 10.1097/00002030-199811000-00028 · DOI
  5. 10.1097/00002030-199905280-00001 · DOI
  6. 10.7326/0003-4819-128-10-199805150-00005 · DOI
  7. 10.1093/infdis/168.6.1490 · DOI
  8. 10.1128/jvi.68.7.4650-4655.1994 · DOI
  9. 10.1128/jvi.68.9.6103-6110.1994 · DOI

Cited by

Sorted by citations

  • Current State of Therapeutics for HTLV-1

    Wang, T. T., Hirons, A., Doerflinger, M., Morris, K. V., Ledger, S., Purcell, D. F. J., Kelleher, A. D., & Ahlenstiel, C. L. (2024) · Viruses · doi:10.3390/v16101616 · Cited by 22

    “Amino acid sequence alignment of HTLV-1 and HIV-1 RT has shown that the two RTs share ~25% sequence identity and ~45% sequence similarity [73].”
    Background

See all 63

Metadata

Authors
Colven, R., Harrington, R. D., Spach, D. H., Cohen, C. J., & Hooton, T. M.
Affiliations
Harborview Medical Center (US)
Corresponding author
Colven, Roy
Venue
Annals of Internal Medicine
Published
2000-09-19
Volume
133
Issue
6
Pages
430-434
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2009347249
Cited by
63
References
1
Citations by year
2024: 3 · 2023: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 2 · 2013: 2
FWCI
2.47
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
HIV infection, antiretroviral therapy discontinuation, viral rebound, CD4 count, plasma HIV RNA, chronic HIV infection
MeSH terms
Adult, Drug Therapy, Combination, Female, HIV, Humans, Male, Middle Aged, RNA, Viral, Syndrome, HIV Infections, Disease Progression, CD4 Lymphocyte Count, Anti-HIV Agents, Viral Load

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Retroviral Rebound Syndrome after Cessation of Suppressive Antiretroviral Therapy in Three Patients with Chronic HIV Infection. https://app.cochat.ai/papers/10.7326/0003-4819-133-6-200009190-00010
The paper
Colven, R., Harrington, R. D., Spach, D. H., Cohen, C. J., & Hooton, T. M. (2000). Retroviral Rebound Syndrome after Cessation of Suppressive Antiretroviral Therapy in Three Patients with Chronic HIV Infection. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-133-6-200009190-00010